MedPath

Metformin, diet and physical activity influence on the overweight and obesity in childre

Phase 1
Conditions
The aim of our study is to establish the effectivenes and safety of metformin use in pediatric obese population
to assess the prevalence of insulin resistance, metabolic syndrome, polycystic ovary syndrome (PCOS), impaired glucose tolerance (IGT) and type 2 diabetes mellitus (T2DM) among overweight and obese children and adolescents in Lithuania, and to determine the effect of targeted interventions (lifestyle and metformin) in controlling obesity and associated diseases risk.
MedDRA version: 14.1Level: PTClassification code 10029883Term: ObesitySystem Organ Class: 10027433 - Metabolism and nutrition disorders
MedDRA version: 14.1Level: PTClassification code 10033307Term: OverweightSystem Organ Class: 10027433 - Metabolism and nutrition disorders
Therapeutic area: Diseases [C] - Hormonal diseases [C19]
Registration Number
EUCTR2011-006352-36-LT
Lead Sponsor
ithuanian University of Health Sciences, Endocrinology Department
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

•Age 10-17 yrs;
•BMI > 85th percentile for age and gender (by IOTF);
•Living in Kaunas and its region;
•No obvious chronic diseases;
•Not on long-term steroid oral / IV treatment;
•Childbearing age ladies using contraception;
•Informed consent of the patient and parents (official caregivers);
Are the trial subjects under 18? yes
Number of subjects for this age range: 100
F.1.2 Adults (18-64 years) no
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

•Age less than 10 or above 17 yrs;
•Diagnosis of type 1 diabetes;
•Chronic illness that may affect physical activity, hormone and metabolic profile;
•Insulin treatment;
•Steroid treatment;
•Planning to move from Kaunas or its region in the period of 1 year;
•Childbearing age ladies non- using contraception, pregnancy planning;
•Protocol refused by the patient or his parents;

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath